Amsterdam Public Health

Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS

de Jonge, A. V., Duetz, C., Bruins, W. S. C., Korst, C. L. B. M., Rentenaar, R., Cosovic, M., Eken, M., Twickler, I., Nijland, M., van der Poel, M. W. M., de Heer, K., Klerk, C. P. W., Strobbe, L., Oosterveld, M., Boersma, R., Koene, H. R., Roemer, M. G. M., van Werkhoven, E., Chamuleau, M. E. D. & Mutis, T., 12 Mar 2024, In: Blood. 8, 5, p. 1094-1104 11 p.

Research output: Contribution to journal › Article › Academic › peer-review

A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients

de Jonge, A. V., van Werkhoven, E., Dinmohamed, A. G., Nijland, M., Zwinderman, A. H., Bossuyt, P. M., Veldhuis, M. S., Rutten, E. G. G. M., Mous, R., Vermaat, J. S. P., Sandberg, Y., de Jongh, E., Bilgin, Y. M., Boersma, R., Koene, H., Kersten, M. J., de Jong, D. & Chamuleau, M. E. D., 1 Dec 2023, In: Blood Cancer Journal. 13, 1, 85.

Research output: Contribution to journal › Article › Academic › peer-review

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial

Vliek, S., Hilbers, F. S., van Werkhoven, E., Mandjes, I., Kessels, R., Kleiterp, S., Lips, E. H., Mulder, L., Kayembe, M. T., Loo, C. E., Russell, N. S., Vrancken Peeters, M-J. T. F. D., Holtkamp, M. J., Schot, M., Baars, J. W., Honkoop, A. H., Vulink, A. J. E., Imholz, A. L. T., Vrijaldenhoven, S., van den Berkmortel, F. W. P. J., & 11 othersMeerum Terwogt, J. M., Schrama, J. G., Kuijer, P., Kroep, J. R., van der Padt-Pruijsten, A., Wesseling, J., Sonke, G. S., Gilhuijs, K. G. A., Jager, A., Nederlof, P. & Linn, S. C., 1 Dec 2023, In: NPJ Breast Cancer. 9, 1, 75.

Research output: Contribution to journal › Article › Academic › peer-review